If successful, the result could be lower Medicare Part D prices for drugs used to create a variety of conditions, such as ...
About 140,400 obese patients in Massachusetts were prescribed medications like Wegovy and Zepbound in 2024, a 255 percent ...
As evidence has mounted that new diabetes and weight loss drugs can provide a variety of health benefits, the FDA has ...
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...
Researchers have found medications like Ozempic and Wegovy may reduce the risk of other conditions or diseases.
The study revealed that weight-loss drugs significantly benefit neurological and behavioral health, including decreased risks ...
A new study published in the Nature Medicine monthly journal highlights the benefits and risks of weight-loss drugs like ...
The newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ...
Drug prices are up for negotiation on 15 Medicare Part D prescription drugs, including popular weight loss drugs such as Ozempic.
New diet drugs are making it easier to lose weight. So does that mean we can stop exercising? Health experts say no. There is ...
Novo is currently in a golden age of growth. Over the last five years, its trailing-12-month revenue grew by 109%, reaching ...
New drugs from public and private companies are expected to saturate the obesity drug market. Novo Nordisk and Eli Lilly are currently dominating the weight loss drug market, but biopharmaceutical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback